SCHEMBL16601883

SCHEMBL16601883

Cc1cc(CN2CCN(S(C)(=O)=O)CC2)ccn1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.52
CYP2D6 P10635 3/20 0.52
CYP2C9 P11712 3/20 0.52
ICAM1 P05362 1/20 0.52
KDR P35968 2/20 0.52
ALDH1A1 P00352 2/20 0.48
CYP2C19 P33261 2/20 0.48
KDM4E B2RXH2 4/20 0.46
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP1A2 P05177 1/20 0.44
LTA4H P09960 1/20 0.44
LMNA P02545 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
PIK3CD O00329 1/20 0.42
PIK3R1 P27986 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12538871 0.84 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C9ICAM1KDR
SCHEMBL4297933 0.84 KDR (0.56) CYP3A4CYP2D6CYP2C9ICAM1KDR
SCHEMBL12606994 0.83 CYP3A4 (0.50) CYP3A4CYP2D6CYP2C9ICAM1KDR
SCHEMBL8038019 0.80 MC4R (0.51) ALDH1A1KDM4ELMNA
SCHEMBL21158864 0.80 ALDH1A1 (0.54) ALDH1A1KDM4ESMN1; SMN2NPSR1
SCHEMBL4553879 0.80 CXCR4 (0.50) ICAM1ALDH1A1SMN1; SMN2
SCHEMBL15450881 0.78 PIK3R1 (0.53) CYP3A4CYP2D6CYP2C9ICAM1KDR
SCHEMBL15450908 0.77 HRH3 (0.57) CYP2D6ICAM1KDRALDH1A1LTA4H
SCHEMBL4757117 0.77 ALDH1A1 (0.46) KDRALDH1A1KDM4ESMN1; SMN2
SCHEMBL15829985 0.77 ALDH1A1 (0.57) ALDH1A1KDM4ERECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993580-B2 Benzothiazole kinase inhibitors and methods of use INTELLIKINE LLC (US) 2015-03-31 US disclosed